NorthCrest Asset Manangement’s Exact Sciences EXAS Stock Holding History

NorthCrest Asset Manangement’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,031	Closed	-$918K	–	804
2025 Q4	$918K	Buy	9,031 +4,327	+92%	+$347K	0.02%	394
2025 Q3	$272K	Buy	+4,704	New	+$235K	0.01%	645

Other funds holding EXAS

VanEck Associates

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

NorthCrest Asset Manangement's EXAS Position: Q1 2026 in Review

NorthCrest Asset Manangement sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 9,031 shares — an estimated $918K sold.

NorthCrest Asset Manangement first reported a position in EXAS in Q3 2025 and held it in 2 quarters. The position peaked at $918K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

NorthCrest Asset Manangement reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
NorthCrest Asset Manangement sold 9,031 Exact Sciences shares in Q1 2026, an estimated $918K.
NorthCrest Asset Manangement first reported a position in Exact Sciences in Q3 2025 and held it in 2 quarters.
NorthCrest Asset Manangement's Exact Sciences position peaked at $918K in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q1 2026, filed 8 Apr 2026.